CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
Eirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Evangelia Legaki, Maria Gazouli, Ioannis E. Koutroubakis
Intest Res. 2021;19(4):461-467.   Published online August 18, 2020
DOI: https://doi.org/10.5217/ir.2020.00042

Excel Download

Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
Intestinal Research. 2021;19(4):461-467   Crossref logo
Link1 Link2 Link3

P639 Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
Journal of Crohn's and Colitis. 2019;13(Supplement_1):S438-S438   Crossref logo
Link1

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease
Inflammatory Bowel Diseases. 2018;24(8):1808-1814   Crossref logo
Link1

Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease - authors' reply
Alimentary Pharmacology & Therapeutics. 2015;42(7):940-941   Crossref logo
Link1 Link2 Link3

Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease
Alimentary Pharmacology & Therapeutics. 2015;42(7):939-940   Crossref logo
Link1 Link2 Link3

Exam 1: Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Gastroenterology. 2015;148(7):e13-e14   Crossref logo
Link1 Link2

Sa1890 DECREASING PATTERNS OF INFLIXIMAB TROUGH LEVELS IN ASYMPTOMATIC INFLAMMATORY BOWEL DISEASE PATIENTS UNDER MAINTENANCE TREATMENT WITH INFLIXIMAB; DOES IT MATTER?
Gastroenterology. 2020;158(6):S-467   Crossref logo
Link1 Link2

Tu1867 - Clinical use of Infliximab Trough Levels During Maintenance in Pediatric Patients with Inflammatory Bowel Disease
Gastroenterology. 2018;154(6):S-1042   Crossref logo
Link1 Link2

P408 Long-term impact of the decrease of infliximab trough levels on the disease course in Inflammatory Bowel Disease patients under maintenance treatment with infliximab
Journal of Crohn's and Colitis. 2020;14(Supplement_1):S375-S376   Crossref logo
Link1 Link2

Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel disease
Digestive and Liver Disease. 2016;48(2):138-143   Crossref logo
Link1 Link2